Join Biologics at the Informa Connect Access USA 2025 Rare Disease Summit
March 18-20, 2025 | Philadelphia, PA
Biologics by Mckesson specialty pharmacy is proud to be a sponsor of the 2025 Informa Connect Access USA Rare Disease Summit. Access USA’s Rare Disease Summit is the industry’s premier event to connect with top leaders and stakeholders from across the life sciences industry. We are thrilled to connect with you at this event and collaborate on innovative ways we can drive better access and care for patients with rare diseases.
Join us at the booth or hear from our experts during their main stage presentation. See below for more information and we’ll see you in Philadelphia!
Revolutionizing Rare Disease Care: Patient-Centric Engagement Through Interdisciplinary Collaboration, Specialty Pharmacies and Technology
Pioneering Perspectives
3:45pm – 4:30pm ET
Explore the future of rare disease care in this forward-thinking session, highlighting the critical importance of patient-centric engagement powered by cutting-edge technology. This session underscores a holistic, technology-driven approach to improving outcomes and elevating the quality of life for those living with rare diseases.
- Learn how interdisciplinary collaboration and specialty pharmacies come together to address the unique challenges of rare diseases
- Discover how leveraging innovative technologies enhances patient engagement, optimizes care delivery, and supports adherence, ultimately meeting the individualized needs of patients and their families
Connect with us at the Rare Disease Summit
Ela Lourido
Vice President/General Manager
Ben Matherne
Sr. Director, Strategic Accounts
George Pachal
Sr. Director, Business Development, Biologics by McKesson
Stephanie Patten
Sr. Director, Rare Disease and Cell and Gene Therapy
Ryan Hampton
Sr. Director, Customer Strategy & Implementations
Daniel Weaver
Director, Clinical Innovation & Strategy
Elsa Tchakoute
Payer Lead Specialist, Cell and Gene Therapy
Chris Alfaro
Sr. Manager, Strategic Accounts